MorphoSys Strengthens Patent Position on anti-CD38 Cancer Program MOR202

News   Dec 06, 2012

 
MorphoSys Strengthens Patent Position on anti-CD38 Cancer Program MOR202
 
 
 
FURTHER INFORMATION
 

This content appears on:

Cancer Research Cell Science

To personalize the content you see on Technology Networks, Log In or Join Today

Login Join
 
 

Comments | 0 ADD COMMENT